ARDX

Ardelyx, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$3.12

Price (1 Year)

$7.77 $2.88

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %20.4 / %30
Non-compliant assets / Total market cap %20.2 / %30
Non-compliant revenue / Total income %2 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis.

Website

Analysis (Turkish): ARDX Hissesi Caiz mi, Helal mi? Ardelyx, Inc. Katılım Analizi